Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
Erik Oude Blenke, Eivor Örnskov, Christian Schöneich, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 112, Iss. 2, pp. 386-403
Open Access | Times Cited: 101

Showing 51-75 of 101 citing articles:

Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine
Cian M. McCrudden, Lindsey Bennie, Philip Chambers, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 536-547
Open Access | Times Cited: 9
Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate
Jesús Hermosilla, Airan Alonso-García, Antonio Salmerón‐García, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1635-1635
Open Access | Times Cited: 8
Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry
Ravi Maharjan, Jae‐Chul Lee, Kyeong Lee, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 6, pp. 803-826
Closed Access | Times Cited: 8
Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-Bcl2 micelleplexes
Anindita De, Ji Hee Kang, Sauraj, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130783-130783
Closed Access | Times Cited: 2
Enhanced BSA Detection Precision: Leveraging High-Performance Dual-Gate Ion-Sensitive Field-Effect-Transistor Scheme and Surface-Treated Sensing Membranes
Yeong-Ung Kim, Won-Ju Cho
Biosensors (2024) Vol. 14, Iss. 3, pp. 141-141
Open Access | Times Cited: 2
Introduction to RNA Vaccines Post COVID-19
Thomas Kramps
Methods in molecular biology (2024), pp. 1-22
Closed Access | Times Cited: 2
Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B
Amerah Parveen, Amal Elkordy
Pathogens (2024) Vol. 13, Iss. 6, pp. 500-500
Open Access | Times Cited: 2
Comparison of capillary electrophoresis-based methods for the analytical characterization of purity and stability of in vitro transcribed mRNA
Prerana Mantri, Bindiya Juneja, Steven Henderson, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 249, pp. 116352-116352
Open Access | Times Cited: 2
β-Cyclodextrin-based geometrically frustrated amphiphiles as one-component, cell-specific and organ-specific nucleic acid delivery systems
Gonzalo Rivero-Barbarroja, José López-Fernández, Inmaculada Juárez-Gonzálvez, et al.
Carbohydrate Polymers (2024) Vol. 347, pp. 122776-122776
Open Access | Times Cited: 2
Development of Nanopackaging for Storage and Transport of Loaded Lipid Nanoparticles
Apanpreet Kaur, Daniel Darvill, Shuning Xiang, et al.
Nano Letters (2023) Vol. 23, Iss. 14, pp. 6760-6767
Open Access | Times Cited: 7
Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying
Khaled AboulFotouh, Benjamin Southard, Huy M. Dao, et al.
International Journal of Pharmaceutics (2023) Vol. 650, pp. 123688-123688
Closed Access | Times Cited: 7
Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-transfection with effective carriers
Rik Oude Egberink, Deni M. van Schie, Ben Joosten, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 202, pp. 114414-114414
Open Access | Times Cited: 2
Recent Advances in Drying and Development of Solid Formulations for Stable mRNA and siRNA Lipid Nanoparticles
Kinnari Santosh Arte, Manlin Chen, Chanakya Patil, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 2
RNA Vaccines: Yeast as a Novel Antigen Vehicle
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1334-1334
Open Access | Times Cited: 6
Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions
Judit Morlà‐Folch, Anna Ranzenigo, Zahi A. Fayad, et al.
Small (2023) Vol. 20, Iss. 17
Open Access | Times Cited: 5
Oligonucleotides and mRNA Therapeutics
Erik Oude Blenke, Raymond M. Schiffelers, Enrico Mastrobattista
Pharmaceutical biotechnology (2024), pp. 291-321
Closed Access | Times Cited: 1
Identification of film-based formulations that move mRNA lipid nanoparticles out of the freezer
Trang Nguyen Kieu Doan, Madison M. Davis, Maria A. Croyle
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102179-102179
Open Access | Times Cited: 1
Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 1
Unleashing the Potential of Ibrutinib-Loaded Nanoparticles for Cancer Treatment—A Comprehensive Review
Razieh Behzadmehr, Sonia Fathi‐karkan, Sobia Razzaq, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 3784-3797
Closed Access | Times Cited: 1
Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects
Urmila Kafle, H-H M Truong, Cường Quốc Nguyễn, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 12, pp. 5944-5959
Closed Access | Times Cited: 1
A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines
Deanna Di Grandi, Daniel M. Dayeh, Keerat Kaur, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115692-115692
Open Access | Times Cited: 4
Analytical techniques for the characterization of nanoparticles for mRNA delivery
Sara S. Nogueira, Eleni Samaridou, Johanna Simon, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 198, pp. 114235-114235
Open Access | Times Cited: 1
Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms
David F. Driscoll, Bruce R. Bistrian
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2560-2564
Closed Access | Times Cited: 1
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 1
Stability Indicating Ion-Pair Reversed-Phase Liquid Chromatography Method for Modified mRNA
Jonathan Currie, Jacob. R Dahlberg, Ester Lundberg, et al.
(2023)
Open Access | Times Cited: 2

Scroll to top